上客户端，和病友交流
点击下载
返回
淋巴瘤
Radhakrishnan Ramchandren M.D.

Radhakrishnan Ramchandren M.D.

内科
Karmanos cancer center

擅长疾病

临床新药咨询

通过咨询找到适合自己的药物

专家会诊咨询

专业、及时的一对一咨询

如果您的问题未能解决，您还可以选择：

医学顾问

极速问诊

2万名名医
7*24小时为您匹配
1对1

找专家

肿瘤专科专家
对症找医专科专治

专家介绍

2015-06-23 10:502955
 ·         Gender

·         Male

·         Multidisciplinary Team(s)

·         Hematologic (Malignant) 

·         Department/Research Program(s)

·         Department of Oncology 

·         Cancer Type(s)

·         Hodgkin's Lymphoma 
Leukemia 
Lymphoma 
Non-Hodgkin's Lymphoma 

·         Contact Info

·         Email:
ramchanr@karmanos.org

·         Education

·         Fellowship
Hematology-Oncology, St. John Health Systems, Providence Hospital
Medical School
Ross University School of Medicine
Residency
Drexel Univeristy College of Medicine - Habnemann University, Philadelphia, PA

·         Professional Memberships/Associations

·         American Society of Hematology 
American Society of Clinical Oncology 
American College of Physicians 

·         Board Certifications

·         American Board of Internal Medicine

·         Clinical Interests

·         Hematology Oncology 

·         Research Interests

·         Lymphoma and myeloma 

·         Publications

·         Results of a Pivotal Phase 2 Study of Brentuximab Vedotin (SGN-35) for Patients with Relapsed or Refractory Hodgkin Lymphoma. Authors: Anas Younes, Ajay K Gopal, Scott E. Smith, Stephen M Ansell, Joseph D Rosenblatt, Kerry J Savage, Radhakrishnan Ramchandren, Nancy L Bartlett, Bruce D Cheson, Sven de Vos1, Andres Forero-Torres, Craig H Moskowitz, Joseph M Connors, Andreas Engert, Emily K Larsen, Dana A Kennedy, Eric L Sievers, and Robert Chen. Journal of Clinical Oncology. In press 2011
Advances in the Treatment of Relapsed or Refractory Hodgkin’s Lymphoma. The oncologist in press 2011 Author: R. Ramchandren.
Cryptococcus Albidus Infection in a Patient Undergoing Autologous Progenitor Cell Transplant. Transplantation. 2004;77(6):956 Authors: Ramchandren R, Gladstone D.
Dasatinib treatment of imatinib resistant CML. Biologics Target and Therapy. Biologics. 2009;3:205-14. Authors: Ramchandren R, Schiffer CA.

1. 添加医学顾问微信，扫描☟二维码

2. 备注【癌种】进病友群

扫描预约专家问诊

专家科普

同类全球会诊
合作伙伴：